Fatimata Bintou Sall

Host institution : University Cheikh anta Diop of Dakar (UCAD), Senegal

Project title: Improving coverage of Intermittent Preventive Treatment for pregnant women and studying factors associated with its effectiveness in the Kedougou Health District (Senegal).

Biography:

Dr. Fatimata Sall is a distinguished physician and researcher with a robust background in hematology, infectious diseases, and public health. She earned her medical degree from the prestigious Cheikh Anta Diop University in Dakar, where she began her research career focusing on hematological cancers. Her early work investigated the role of infectious agents such as Epstein-Barr virus and Plasmodium falciparum in the development of certain hematological malignancies. For her medical doctoral thesis, she explored the association between lymphomas and serological markers of Plasmodium falciparum.

Dr. Sall first worked as a medical interne at Dakar hospitals from January 2012 to December 2016. She specialized in Clinical Biology and obtained a Master's degree in Biological Hematology. In October 2017, she commenced a PhD in Molecular and Cellular Biology at the Doctoral School of Oncology, University of Paris-Saclay, in joint supervision with Cheikh Anta Diop University. Her doctoral research focused on the role of Epstein-Barr virus and Human Immuno-deficiency Virus in the onset of Burkitt's lymphoma, which she successfully defended in May 2021.

Recognizing a need to deepen her expertise in epidemiology, research methodology, and statistics, Dr. Sall pursued a Master's in Public Health with a focus in Epidemiology, supported by a scholarship from WHO/TDR. This program emphasized Implementation Research (IR) on tropical diseases.

For her master’s thesis, she investigated the factors associated with uptake of intermittent preventive treatment (IPT) of malaria in pregnant women, in the Kedougou Health district (southeastern Senegal), which sparked her new enduring interest in IR.

Since April 2022, Dr. Sall has been a research assistant at the University of Thies, working in Professor Jean Louis Ndiaye's team. Her research primarily focuses on malaria chemoprevention in children (Seasonal Malaria Chemoprevention) and pregnant women (IPT), as well as on neglected tropical diseases. In the context of the MARCAD-Plus project, she aims to co-develop an intervention with stakeholders and the community in the Kedougou Health District to improve IPT coverage among pregnant women. Beyond improving coverage, her interests extend to factors that might undermine.

the benefits of IPT, such as Sulfadoxine-Pyrimethamine resistance and comorbidities like intestinal parasitic infections in pregnant women.

Dr. Sall is committed to leveraging her multidisciplinary expertise to enhance public health outcomes and advance the fight against malaria and other tropical diseases. Her work embodies a blend of clinical insights, rigorous research, and a deep commitment to community health.

• Prev
• Next